PHARMATHENE INC's ticker is PIP and the CUSIP is 71714G102. A total of 90 filers reported holding PHARMATHENE INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $0 | -100.0% | 200 | -99.9% | 0.00% | -100.0% |
| Q4 2016 | $694,000 | +4526.7% | 213,679 | +4082.4% | 0.00% | – |
| Q3 2016 | $15,000 | 0.0% | 5,109 | -18.6% | 0.00% | – |
| Q2 2016 | $15,000 | +650.0% | 6,277 | +527.7% | 0.00% | – |
| Q1 2016 | $2,000 | 0.0% | 1,000 | -10.0% | 0.00% | – |
| Q4 2015 | $2,000 | -33.3% | 1,111 | -44.4% | 0.00% | – |
| Q3 2015 | $3,000 | -25.0% | 2,000 | -1.1% | 0.00% | – |
| Q2 2015 | $4,000 | +33.3% | 2,023 | +1.2% | 0.00% | – |
| Q1 2015 | $3,000 | -25.0% | 2,000 | -5.1% | 0.00% | – |
| Q4 2014 | $4,000 | -33.3% | 2,107 | -39.8% | 0.00% | – |
| Q3 2014 | $6,000 | +20.0% | 3,500 | 0.0% | 0.00% | – |
| Q2 2014 | $5,000 | -50.0% | 3,500 | -35.0% | 0.00% | – |
| Q1 2014 | $10,000 | +25.0% | 5,384 | +25.2% | 0.00% | – |
| Q4 2013 | $8,000 | -27.3% | 4,300 | -14.4% | 0.00% | – |
| Q3 2013 | $11,000 | +57.1% | 5,022 | +16.8% | 0.00% | – |
| Q2 2013 | $7,000 | – | 4,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 520,000 | $422,000 | 0.44% |
| FIRST QUADRANT LLC/CA | 1,655,539 | $1,343,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 1,118,005 | $907,000 | 0.02% |
| CIGNA INVESTMENTS INC /NEW | 303,239 | $246,000 | 0.02% |
| Burt Wealth Advisors | 17,870 | $15,000 | 0.01% |
| Sullivan, Bruyette, Speros & Blaney, LLC | 126,346 | $103,000 | 0.01% |
| ClariVest Asset Management LLC | 322,970 | $262,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 594,444 | $482,000 | 0.01% |
| Renaissance Technologies | 4,790,931 | $3,888,000 | 0.01% |
| Mraz, Amerine & Associates, Inc. | 20,000 | $15,000 | 0.01% |